{"id":"https://openalex.org/W2313328174","doi":"https://doi.org/10.1158/0008-5472.sabcs12-p3-05-04","title":"Abstract P3-05-04: Intra-tumor heterogeneity as a predictor of therapy response in HER2 positive breast cancer","display_name":"Abstract P3-05-04: Intra-tumor heterogeneity as a predictor of therapy response in HER2 positive breast cancer","publication_year":2012,"publication_date":"2012-12-01","ids":{"openalex":"https://openalex.org/W2313328174","doi":"https://doi.org/10.1158/0008-5472.sabcs12-p3-05-04","mag":"2313328174"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs12-p3-05-04","doi":"https://doi.org/10.1158/0008-5472.sabcs12-p3-05-04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs12-p3-05-04","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004682686","display_name":"Inga Hansine Rye","orcid":"https://orcid.org/0000-0002-0821-0585","observed_orcids":["https://orcid.org/0000-0002-0821-0585"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"IH Rye","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055776119","display_name":"\u00c5slaug Helland","orcid":"https://orcid.org/0000-0002-5520-0275","observed_orcids":["https://orcid.org/0000-0002-5520-0275"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"A\u030a Helland","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057586786","display_name":"Anna Barbro S\u00e6tersdal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"A S\u00e6tersdal","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001565523","display_name":"Bj\u00f8rn Naume","orcid":"https://orcid.org/0000-0002-6811-9476","observed_orcids":["https://orcid.org/0000-0002-6811-9476"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"B Naume","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019153476","display_name":"Vanessa Almendro","orcid":"https://orcid.org/0000-0002-4242-2573","observed_orcids":["https://orcid.org/0000-0002-4242-2573","https://orcid.org/0009-0007-1792-6466"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"V Almendro","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014395742","display_name":"Korn\u00e9lia Poly\u00e1k","orcid":"https://orcid.org/0000-0002-5964-0382","observed_orcids":["https://orcid.org/0000-0002-5964-0382"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"K Polyak","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043573672","display_name":"A.L. B\u00f8ressen-Dale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"A-L B\u00f8ressen-Dale","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026252394","display_name":"HG Russnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["NO","US"],"is_corresponding":false,"raw_author_name":"HG Russnes","raw_affiliation_strings":["Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","Institute for Cancer Research, Oslo, Norway","Oslo University Hospital, Oslo, Norway","University of Oslo, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway; Oslo University Hospital, Oslo, Norway; University of Oslo, Oslo, Norway; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Hospital Cli\u0301nic, Barcelona, Spain","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I136199984","https://openalex.org/I184942183","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Institute for Cancer Research, Oslo, Norway","institution_ids":[]},{"raw_affiliation_string":"Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]},{"raw_affiliation_string":"University of Oslo, Oslo, Norway","institution_ids":["https://openalex.org/I184942183"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"24_Supplement","first_page":"P3","last_page":"05"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intratumor-heterogeneity","display_name":"intratumoral heterogeneity","score":0.9480000138282776},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/neoadjuvant-therapy-response","display_name":"neoadjuvant therapy response","score":0.8830000162124634},{"id":"https://openalex.org/keywords/her2-gene-copy-number","display_name":"HER2 gene copy number","score":0.9120000004768372},{"id":"https://openalex.org/keywords/estrogen-receptor-expression","display_name":"estrogen receptor expression","score":0.7379999756813049},{"id":"https://openalex.org/keywords/her2-expression","display_name":"HER2 expression","score":0.7210000157356262},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7495443820953369},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7316604256629944},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7105616331100464},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5863068103790283},{"id":"https://openalex.org/C2778236600","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Immunofluorescence","level":3,"score":0.5213478803634644},{"id":"https://openalex.org/C2777542201","wikidata":"https://www.wikidata.org/wiki/Q1336182","display_name":"Fluorescence in situ hybridization","level":4,"score":0.5211924910545349},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5185928344726562},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4667397439479828},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45549046993255615},{"id":"https://openalex.org/C64618202","wikidata":"https://www.wikidata.org/wiki/Q3733697","display_name":"Genetic heterogeneity","level":4,"score":0.4534175992012024},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.44924822449684143},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4437524974346161},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.44234782457351685},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39093464612960815},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36058270931243896},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35533350706100464},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2502444386482239},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2303464412689209},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2188543975353241},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.19122439622879028},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1363946795463562}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs12-p3-05-04","doi":"https://doi.org/10.1158/0008-5472.sabcs12-p3-05-04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs12-p3-05-04","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2742841696","https://openalex.org/W7129286072","https://openalex.org/W3157823694","https://openalex.org/W2797524035","https://openalex.org/W4392454739","https://openalex.org/W7213555337","https://openalex.org/W4327846151","https://openalex.org/W7129427712","https://openalex.org/W2625378252","https://openalex.org/W4411604062"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Breast":[2],"cancer":[3,106],"is":[4,38,304],"known":[5,39],"to":[6,50,69,80,90,241,277,300,328],"be":[7,326,337],"a":[8,25,57,169,215,250,265,305],"heterogeneous":[9,295],"disease":[10],"both":[11,134,311],"at":[12,55],"the":[13,41,88,120,126,154,196,230,233,242,245,260,282,285,289,317,330,334],"clinical":[14],"and":[15,28,34,46,61,81,95,125,137,140,148,161,178,185,189,198,227,229,253,288,313,333],"molecular":[16],"level.":[17],"In":[18,259],"addition,":[19],"heterogeneity":[20,45,72],"can":[21,30],"also":[22],"exist":[23],"within":[24],"given":[26],"tumor,":[27],"subpopulations":[29],"have":[31],"distinct":[32],"phenotypic":[33,135,312],"genomic":[35,141,274,314],"features.":[36],"Little":[37],"about":[40],"relationship":[42],"between":[43],"intra-tumor":[44,71],"prediction":[47],"of":[48,59,119,145,187,218,232,310],"response":[49,89,124,213],"treatment.":[51,93,163,271,301],"This":[52,237],"study":[53],"aimed":[54],"using":[56],"combination":[58],"immunofluorescence":[60,191],"fluorescence":[62,176],"in":[63,73,153,168,205,239,281,316,320],"situ":[64],"(FISH)":[65],"technique":[66],"(\u201cdouble":[67],"immunoFISH\u201d)":[68],"identify":[70],"tumors":[74],"from":[75,244],"neo-adjuvant":[76,103],"treated":[77,104],"patients":[78,98,121,210,261],"prior":[79,276,299],"after":[82,162,270,296],"therapy,":[83],"searching":[84],"for":[85,308],"features":[86],"predicting":[87],"neo":[91],"adjuvant":[92],"Material":[94],"methods:":[96],"Twentytwo":[97],"diagnosed":[99],"with":[100,174,180,211,262],"HER2":[101,138,146,188,197,222],"positive,":[102],"breast":[105],"((3\u20134":[107],"FEC100":[108],"followed":[109],"by":[110],"4":[111],"docetaxel":[112],"plus":[113],"trastuzumab,":[114],"3qw)":[115],"were":[116,151,166,192,203,254],"selected.":[117],"Half":[118],"had":[122,128],"complete":[123,246,286],"others":[127],"partial":[129,212,263],"response.":[130],"By":[131],"double":[132],"immunoFISH":[133,303],"(ER":[136],"protein)":[139],"changes":[142],"(copy":[143],"number":[144],"gene":[147],"centromere":[149,199],"17)":[150],"assessed":[152],"same":[155,318],"cells":[156],"simultaneously":[157],"on":[158],"biopsies":[159],"before":[160],"The":[164,183,209,273,323],"samples":[165],"photographed":[167],"Zeiss":[170],"Axio":[171],"Imager":[172],"M1":[173],"5":[175],"channels":[177],"analyzed":[179],"axiovision":[181],"software.":[182],"intensity":[184],"localization":[186],"ER":[190,257],"semi-quantitatively":[193],"estimated":[194],"while":[195],"17":[200],"FISH":[201],"signals":[202],"counted":[204],"100":[206],"cells.":[207],"Results:":[208],"displayed":[214],"high":[216],"grade":[217],"cell-to-cell":[219],"diversity":[220,252,267,331],"regarding":[221],"copy":[223],"number,":[224],"nuclear":[225],"shape":[226],"size":[228],"expression":[231],"membrane":[234],"protein":[235],"HER2.":[236],"was":[238,268,279,292],"contrast":[240],"results":[243,335],"responders":[247],"who":[248],"showed":[249],"reduced":[251],"more":[255,294],"frequently":[256],"negative.":[258],"response,":[264],"higher":[266,280],"seen":[269],"Conclusion:":[272],"variability":[275],"therapy":[278],"partial-responders":[283],"vs.":[284],"responders,":[287],"remaining":[290],"tumor":[291],"even":[293],"treatment":[297],"than":[298],"Double":[302],"valuable":[306],"tool":[307],"visualization":[309],"alterations":[315],"cell":[319],"FFPE":[321],"sections.":[322],"cohort":[324],"will":[325,336],"expanded":[327],"explore":[329],"further,":[332],"presented.":[338],"Citation":[339],"Information:":[340],"Cancer":[341],"Res":[342],"2012;72(24":[343],"Suppl):Abstract":[344],"nr":[345],"P3-05-04.":[346]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}